Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
Trial record 1 of 1 for:    NCT00991029
Previous Study | Return to List | Next Study

Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke (POINT) Trial (POINT)

This study is currently recruiting participants. (see Contacts and Locations)
Verified July 2016 by University of California, San Francisco
Neurological Emergencies Treatment Trials Network (NETT)
Medical University of South Carolina
The EMMES Corporation
Information provided by (Responsible Party):
University of California, San Francisco Identifier:
First received: October 6, 2009
Last updated: July 18, 2016
Last verified: July 2016